Propofol PK/PD study examines exposure and anesthetic response in chronic kidney disease
Academic source · The Journal of Clinical Pharmacology / PubMed
Source published: · Event / reporting date: 2026-11-01
Site published: 2026-11-08 · Updated: 2026-11-08
This source is linked automatically. Choose a question to get started.
What the paper reports
An abstract describes a prospective single-center study enrolling 38 surgical patients with chronic kidney disease. Model development used 287 concentration samples and bispectral-index data from 35 patients. Creatinine clearance was an important pharmacokinetic covariate; more advanced impairment was associated with higher exposure and longer emergence. External validation is needed before translating the model into individualized dosing decisions.
Why this paper is included
Renal-function effects may inform special-population study design and model validation, while the small single-center dataset limits generalization.
The interpretation above is analysis, not a conclusion attributed to the original source.
Read the original source ↗Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections